GCF
28.9.2021 14:49:09 CEST | Business Wire | Press release
The 2022 edition of the Global Cybersecurity Forum (GCF) will be held on 1st and 2nd of February 2022 in Riyadh under the High Patronage of the Custodian of the Two Holy Mosques King Salman bin Abdulaziz Al Saud.
The GCF 2022 theme, Rethinking the Global Cyber Order , will focus on the root challenges in cybersecurity and explore how the global cyber community can seize upon the many benefits cyberspace offers to humanity. Building off the momentum from its previous forums, the GCF will continue to grow into an action-oriented global platform that integrates the global cybersecurity community. Through its annual events, continuous research, design and launch of new initiatives, and more, the GCF aims to catalyze socioeconomic change, push the knowledge boundaries on core cybersecurity topics, foster investment and build the foundations for global cooperation in cyberspace.
Interactive and dynamic discussions and sessions will engage prominent speakers and participants representing high-level policy makers, industry leaders, experts from NGOs, international organizations, and academia driving the conversation from a range of perspectives and experiences and cover a range of sub-themes that include:
- The evolving international order in cyberspace;
- The current and future state of cybersecurity threats;
- Technologies of the future as solutions to threats;
- The human dimensions of cybersecurity in the future of work;
- Leveraging market forces and economic incentives
- Bridging global cyber divides and strengthening human-centric cybersecurity
The GCF, hosted by the National Cybersecurity Authority (NCA), was launched in February 2020, during the Kingdom of Saudi Arabia’s G20 Presidency, as a global platform aiming to build a more resilient and better cyberspace for all. The platform emphasizes the importance of international collaboration among diverse stakeholders and nations to accomplish this goal. In line with these objectives, GCF has convened former Heads of States, industry leaders, policymakers, senior representatives from International Organizations, prominent academics and thought leaders from across the globe, and executives from the finance, health, energy, and transport sectors.
When COVID struck, the GCF hosted its first Virtual Dialogue entitled “Cyberspace: What Now, What Next?”, attracting over 250,000 individuals from more than 100 countries. The multi-disciplinary sessions highlighted a series of key themes for the global cybersecurity community, including economic incentives, the talent gap, investment, trust, cyber diplomacy, integrated awareness, and cyber conflict readiness.
The GCF team welcomes global participation in the coming event and looks forward to expanding dialogue and driving action together to create a better cyberspace for all.
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20210928005711/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yamaha to Acquire Disguise, Expanding Its Capabilities in Integrated Audio, Video, Lighting and Media13.11.2026 08:00:00 CET | Press release
Acquisition combines Yamaha’s audio expertise with Disguise’s software and media server technologies Yamaha Corporation today announced an agreement to acquire Disguise Technologies Limited (“Disguise”), a London-based provider of software and media server technologies for live and immersive experiences. Yamaha will acquire the company by purchasing all shares in its parent, Butterfly Topco Limited. The acquisition will expand Yamaha’s capabilities beyond audio into integrated audio, video, lighting and media solutions, in line with its strategy to expand beyond hardware into software and services. By combining Yamaha’s audio expertise and global reach with Disguise’s software, technologies and worldwide partner network, the companies will be better positioned to deliver immersive experiences across live entertainment, sports and other venues. Disguise’s technology powers live and immersive experiences worldwide, including tours by Beyoncé and Taylor Swift and venues such as New York’s
Mexico Becomes the First Market Worldwide to Receive Approval for Galderma’s Restylane® Shaype™ for Both Chin and Its First Jawline Indication13.11.2026 07:00:00 CET | Press release
Restylane Shaype is now approved in Mexico for temporary augmentation in the chin area and improvement of jawline definition,1 with launch anticipated in H1 2027 Already approved across various markets globally for the chin area,2 this marks Restylane Shaype’s first approval for the jawline worldwide1 The first-and-only shaper on the hyaluronic acid (HA) market, Restylane Shaype features the firmest HA gel available and is powered by proprietary NASHA HD™ technology, developed to build and shape on bone for instant, natural-looking contour and definition3-6 The approval reinforces Galderma's commitment to advancing innovation in the HA category, enabling the company to meet diverse patient needs Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that Restylane Shaype has been approved for temporary augmentation in the chin area and improvement of jawline definition in Mexico.1 This is the product’s first approval globally for the jawline, and further expan
vVARDIS Announces Pricing of Initial Public Offering13.11.2026 06:02:00 CET | Press release
vVARDIS Holding AG (“vVARDIS”), a Swiss healthcare company operating in the dental med-tech sector, today announced the pricing of its initial public offering of 9,722,223 Class A ordinary shares at a public offering price of $18.00 per share. In connection with the offering, vVARDIS has granted the underwriters a 30-day option to purchase up to an additional 1,458,333 Class A ordinary shares at the initial public offering price to cover over-allotments. The Class A ordinary shares are expected to begin trading on the New York Stock Exchange on November 13, 2026 under the symbol “VVVV.” The closing of the offering is expected to occur on or about November 16, 2026 subject to the satisfaction of customary closing conditions. Goldman Sachs & Co. LLC and J.P. Morgan are acting as joint bookrunning managers for the offering, with William Blair, UBS Investment Bank and Deutsche Bank Securities acting as bookrunners. A registration statement on Form F-1 relating to the offering has been file
Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4*12.11.2026 23:07:00 CET | Press release
The multi-level takeover includes a Throne Room, interactive photo opportunities, special lighting, and more The Empire State Building (ESB) is the gateway to Mount Olympus in Percy Jackson’s world, and now fans can experience the magic like never before. On Nov. 16, the Empire State Building Observation Deck (ESBOD) will unveil “Olympus Awaits,” a multi-level “Percy Jackson and the Olympians” takeover, in partnership with Disney+. The immersive takeover – included with every Observation Deck ticket – will feature an epic Throne Room, interactive photo opportunities, surprise giveaways, ESB x “Percy Jackson” merch, and more, available through Dec. 4, 2026.* This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112442266/en/ Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4* “This immersive NYC experience
Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application12.11.2026 18:09:00 CET | Press release
Veristat’s InStat™ delivers submission-ready tables, listings, and figures (TLFs) in one week using validated statistical engines, shortening the critical path from database lock to submission VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced that it has partnered with Clene Nanomedicine to cut the time to deliver biostatistical outputs for a pivotal ALS drug application submission by 80%. Veristat reduced the time from study data to validated tables, listings and figures (TLFs) from up to six weeks to just one week. Clene, a late-stage biotech company, leveraged Veristat’s recently launched InStat™ platform, the industry’s first zero-code, fully automated solution to accelerate clinical trial processes. Biostatistical TLFs sit on the critical path for submissions, yet most sponsors rely on antiquated processes that involve slow, manual workflows to produce them, making post-database lock one of the biggest bottlenecks
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
